The mitochondrial phospholipid cardiolipin (CL) is required for oxidative phosphorylation. Oxidation of CL results in the disruption of CL-cytochrome c binding and the induction of apoptosis. Large variations in the acyl-chain residues of CL have been reported, but evidence as to whether these variants exert distinct biological effects has been limited. We have studied the acyl-chain composition of CL in lymphocytes, and found marked differences between highly and slowly proliferating cells. In fast growing cells, we detected a decreased number of double bonds, and a higher amount of C16 acyl-chain residues in CL, compared with slower growing cells. However, fewer C18 acyl-chain residues were found in CL from fast growing cells compared with slower proliferating cells. Our results suggest a functional link between acyl-chain composition of CL and cell proliferation.
LecocqF, BallouCE. On the structure of cardiolipin. Biochemistry1964;3:976–80
2.
De KroonAI, DolisD, MayerA, LillR, de KruijffB. Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane?Biochim Biophys Acta1997;1325:108–16
3.
KiebishMA, HanX, ChengH, ChuangJH, SeyfriedTN. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res2008;49:2545–56
4.
LiJ, RomestaingC, HanX, LiY, HaoX, WuY, SunC, LiuX, JeffersonLS, XiongJ, LanoueKF, ChangZ, LynchCJ, WngH, ShiY. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab2010;12:154–64
5.
van GestelRA, RifkenJ, SurinovaS, O'FlahertyM, HeckAJR, KillianJA, de KroonAEPM, SlifperM. The influence of the acyl-chain composition of cardiolipin on the stability of mitochondrial complexes; an unexpected effect of cardiolipin in α-ketoglutarate dehydrogenase and prohibitin complexes. J Proteom2010;73:806–14
6.
SchlameM, RenM. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett2006;560:5450–5
7.
ZhouW, MukherjeeP, KiebishMA, MarkisWT, MantisJG, SeyfriedTN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab(Lond)2007;4:5
8.
HanX, YangJ, YangK, ZhaoZ, AbendscheinDR, GrossRW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stage of diabetes: a shot gun lipodomics study. Biochemistry2007;46:6417–28
9.
PopeS, LanJM, HealesSJ. Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target?Biochim Biophys Acta2008;1777:794–9
10.
CanutoRA, BioccaME, MuzioG, DianzaniMU. Fatty acid composition of phospolipids in mitochondria and microsomes during diethynitrosamine carcinogenesis in rat liver. Cell Biochem Fund1989;7:11–9
11.
HartzJW, MorionRI, WalteMM, MorrisHP. Correlation of fatty acyl composition of mitochondrial and microsomal phospolipid with growth rate of rat hepatomas. Lab Invest1982;46:73–8
12.
HochFL. Cardiolipins and biomembrane function. Biochim Biophys Acta1992;1113:71–133
13.
HochFL. Cardiolipins and mitochondrial proton-selective leakage. J Bioenerg Biomembr1998;30:511–32
14.
JahnkeVE, SabidoO, DefourA, CastellsJ, LefaiE, RousselD, FreyssenetD. Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells. PLoS One2010;5:e8637
15.
KaltoftK, BisballeS, RasmussenHF, Thestrup-PedersenK, ThomsenK, SterryWA. Continuous T-cell line from a patient with Sezary syndrome. Arch Dermatol Res1987;279:293–8
16.
SchlameM, ShanskeS, DotyS, KönigT, SculcoT, DimauroS, BlanckT. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J Lipid Res1990;40:1585–92
17.
ValianpourF, WandersRJA, BarthPG, OvermarsH, van GennipAH. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin Chem2002;48:1390–7
18.
LowryOH, RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951;193:265–75
19.
KaganVE, TyurinVA, JiangJ, TyurinaYY, RitovVB, AmoscatoAA, OsipovAN, BelikovaNA, KapralovAA, KiniV, VlasovaII, ZhaoQ, ZouM, DiP, SvistunenkoDA, KurnikovIV, BorisenkoGG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol2005;1:223–32
20.
KiebishMA, HanX, ChengH, SeyfriedTN. In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN Neurol2009;1:e00011
21.
StruchkovVA, StrazhevskayaNB, ZhdanovRI. DNA-bound lipids of normal and tumor cells: retrospective and outlooks for functional genomics. Bioelectrochemistry2002;58:23–30
22.
ZhdanovRI, StruchkovVA, DyabinaO, StrazhevskayaNB. Chromatin-bound cardiolipin: the phospholipid of proliferation. Cytobios2001;106:55–61
23.
StruchkovVA, StrazhevskayaNB. Structural and functional aspects of nuclear lipids in normal and tumor cells. Biochemistry (Mosc.)2000;65:525–45
24.
HainesTA. A new look at cardiolipin. Biochim Biophys Acta2009;1788:1997–2002
25.
HatchGM. Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells (Review). Int J Mol Med1998;1:33–41
26.
SchlameM, RüstowB. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem J1990;272:589–95
27.
BielskiBH, ArudiRL, SutherlandMW. A study of the reactivity of H2O2/O2− with unsaturated fatty acids. J Biol Chem1983;4759–61
28.
KapralovAA, YanamalaN, TyurinaYY, CastroL, AriasAS, VladimirovYA, MaedaA, WeitzAA, PetersonJ, MylnikovD, DemicheliV, TortoraV, Klein-SeetharamanJ, RadiR, KaganVE. Topography of tyrosine residues and their involvement in peroxidation of polyunsaturated cardiolipin in cytochrome c/cardiolipin peroxidase complexes. Biochim Biophys Acta2011;808:2147–55
29.
SchugZT, GottliebE. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta2009;1788:2022–31
30.
PetrosilloG, RuggieroFM, PistoleseM, ParaiesG. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett2001;509:435–8
31.
KaganVE, BayirHA, BelikovaNA, KapralovO, TyurinaYY, TyurinVA, JiangJ, StoyanovskyDA, WipfP, KochanekPM, GreenbergerJS, PittB, ShvedovaAA, BorisenkoG. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med2009;46:1439–53
32.
ScorranoL. Caspase-8 goes cardiolipin: a new platform to provide mitochondria with microdomains of apoptotic signals?J Cell Biol2008;183:579–81
RigouletM, YoboueED, DevinA. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal2011;14:459–68
35.
PearceEL. Metabolism in T-cell activation and differentiation. Curr Opin Immunol2010;22:314–20
36.
WarburgO. On the origin of cancer cells. Science1956;123:309–14
37.
BauerDE, HatzivassiliouG, ZhaoF, AndreadisC, ThompsonCB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene2005;24:6314–22
38.
BensingerSJ, BradleyMN, JosephSB, ZelcerN, JanssenEM, HausnerMA, ShihR, ParksJS, EdwardsPA, JamiesonBD, TontonozP. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell2008;134:97–111
39.
BerwickDC, HersI, HeesomKJ, MouleSK, TavareJM. The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J Biol Chem2002;277:33895–900
40.
HatzivassiliouG, ZhaoF, BauerDE, AndreadisC, ShawAN, DhanakD, HingoraniSR, TuvesonDA, ThompsonCB. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell2005;8:311–21
41.
PuriP, WiestMM, CheungO, MirshahiF, SargeantC, MinHK, ContosMJ, SterlingRK, FuchsM, ZhouH, WatkinsSM, SanyalAJ. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology2009;50:1827–38
42.
HostetlerKY, ZennerBD, MorrisHP. Phospholipid content of mitochondrial and microsomal membranes from Morris hepatomas of varying growth rates. Cancer Res1979;38:2978–83
43.
SunB, ZhangX, TalathiS, CummingsBS. Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms. J Pharmacol Exp Ther2008;326:59–68
44.
ValianpourF, WandersRJ, OvermarsH, VazFM, BarthPG, van GennipAH. Linoleic acid supplemention of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment. J Lipid Res2003;44:560–6
